Form 4 for MRK Merck & Co.
Accepted 2023-02-13 00:00:00 ET · period of report 2023-02-10 · accession 0001127602-23-004855 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-13 | 2023-02-10 | MRK | Williams David Michael | EVP, Chief Info, Digital Off | M - OptEx | $106.72 | +1,205 | 12.5K | +11% | +$128.6K |
| D | 2023-02-13 | 2023-02-10 | MRK | Williams David Michael | EVP, Chief Info, Digital Off | F - Tax | $106.72 | -413 | 12.1K | -3% | -$44.1K |
| D | 2023-02-13 | 2023-02-10 | MRK | Williams David Michael | EVP, Chief Info, Digital Off | M - OptEx | $0.00 | -1,205 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-10 | M | A | 1,205 | $106.72 | 12,504.89 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-10 | F | D | 413 | $106.72 | 12,091.89 | D | — | — | (F1) Holdings include shares acquired in dividend reinvestment transactions. |
| 3 | Derivative | Restricted Stock Unit | 2023-02-10 | M | D | 1,205 | $0.00 | 0 | D | — · 2021-02-10 to 2023-02-10 | 1,205 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. (F3) These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 2/10/2021, 2/10/2022 and 2/10/2023. |